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Purpose. To evaluate visual performance for near, intermediate, and distant vision; complaints of photic phenomena, and patient
satisfaction with the new diﬀractive multifocal IOL used in eyes which underwent phacoemulsiﬁcation. Methods.T w ot h o u s a n d
and ﬁve hundred consecutive eyes undergoing Tecnis ZM900 multifocal IOL implantation were included in this retrospective
analysis. The minimum followup of 3 months was required after the surgery. Patients were assessed for uncorrected near visual
acuity(UNVA)ataﬁxeddistance(33cm),uncorrectedintermediatevisualacuity(UIVA)at60cm,anduncorrecteddistancevisual
acuity (UDVA). Using a subjective questionnaire, patients satisfaction, their independence from using glasses, and the perception
ofglareandhalophenomenawerealsoevaluatedatthelastfollow-up.Results.Twothousandandﬁvehundredeyesof1558patients
underwentcataract surgeryandTecnis ZM900multifocalIOLimplantation.Fourhundredandeightyseven patients(31.3%)were
men, and 1071 (68.7%) were women. The mean age of the patients was 66.17 years. A UDVA of 20/30 or better was achieved by
85% of eyes. A UNVA of J1 was achieved by 93.7% of eyes and that of J2 or better was achieved by 98%. A UIVA of J4 or better
was achieved by 65% and J5 or better was achived by more than 82.8% of the eyes in the study. Glare and halos were reported as
severe by only 6.1% and 2.12% of patients, respectively. Ninety seven percent reported complete spectacle independence and 88%
stated that they are totally satisﬁed with their quality of vision and would choose to have the same lens implanted again after the
ﬁrst implant. Five percent of the eyes in the study needed a second procedure (enhancement) to achieve a better visual result. No
patient underwent lens exchange. Conclusion. Excellent near, intermediate, and distant vision was observed in patients implanted
withtheTecnisZM900diﬀractivemultifocalIOL.Spectacleindependenceandaminimumoccurrenceofphoticphenomenamake
this IOL an excellent option in patients with cataract.
1.Introduction
Advances in both IOL and phacoemulsiﬁcation technology
have enabled surgery to evolve from a procedure concerned
with the safe removal of the cataract to a much more
reﬁned procedure to achieve the best possible postoperative
refractive result. Management of presbyopia is a challenge
for refractive surgeons. The standard intraocular lens (IOL)
implanted after cataract extraction to replace the focusing
power of the natural lens has a single, ﬁxed, focal length
(monofocal IOL). Multifocal IOLs have been designed with
the intention of providing good unaided distant, intermedi-
ate, and near vision [1–5]. Along with this, the development
of aspherical IOLs has meant an incremental increase in
visual quality for patients who undergo multifocal IOL
implants [6–9].
Multifocal IOLs address the principle of simultaneous
vision. Incoming light is divided between 2 lens powers: one
for distance vision and one for near vision [4]. Clinically,
multifocal IOLs have been reported to provide patients
with functional near and distant vision with acceptable
satisfaction. Reduced image contrast and unwanted visual
phenomena, including glare and halos, have also been
associated with multifocal IOL performance [4–6].
The Tecnis (AMO - Model ZM900) multifocal IOL is
a second-generation silicone diﬀractive 3-piece lens. The
innovative aspect of the Tecnis multifocal IOL is an anterior
modiﬁed prolate surface, which neutralizes the negative2 Journal of Ophthalmology
impact of spherical aberrations on function vision and a
posterior full diﬀractive multifocal surface. The addition
power is +4.0 at lens plane. We present a large single-site
series of patients who had a Tecnis ZM900 multifocal IOL
implanted after cataract surgery.
The purpose of this study was to assess distance,
intermediate, and near visual performance in patients who
had cataract surgery with Tecnis ZM900 multifocal IOL
implantation.
2. Patientsand Methods
This retrospective study included patients with cataract,
no indication of existing ocular pathology, unsatisfactory
correction with glasses, visual potential in operative eye of
20/25orbetter,andlessthan1.50diopters(D)oftopography
cylinder. Patients were oﬀered the opportunity to be part
of a clinical trial in which they would be allocated to
have cataract surgery with a Tecnis multifocal IOL implant.
Written informed consent was obtained from all patients
before surgery, and the study was approved by the local
ethics committee. Exclusion criteria were history of ocular
trauma or prior ocular surgery, glaucoma or intraocular
pressure greater than 21mmHg, amblyopic eyes, retinal
abnormalities, diabetes mellitus, steroid or immunosuppres-
sive treatment, corneal and pupil abnormalities, capsule or
zonular abnormalities, and connective tissue diseases. The
selected lens used in this study was the Tecnis multifocal IOL
(Model ZM900, AMO): a silicon foldable 3-piece IOL with
6.00mm biconvex optic.
Preoperativevisitincludedanassessmentofsubjectqual-
iﬁcations for inclusion in the study according to the protocol
inclusion/exclusion criteria. Key data collection was medical
history, uncorrected distance visual acuity (UDVA), best
correcteddistancevisualacuity(CDVA),sphericalequivalent
(SE), and a subject lifestyle questionnaire. All patients
had a complete ocular examination including refraction,
intraocular pressure, and slit-lamp and fundus examination
with dilated pupil. Preoperative testing included axial length
measurementbypartialcoherenceinterferometry(IOLMas-
ter; Carl Zeiss Meditec, Jena, Germany). Intraocular lenses
were calculated for a ﬁnal refraction of 0 (emmetropia). Data
recorded from the surgical procedure included lens serial
number, lens power, and complications.
The postoperative evaluation included uncorrected dis-
tance visual acuity (UDVA), uncorrected intermediate visual
acuity (UIVA), uncorrected near visual acuity (UNVA),
best corrected distance visual acuity (CDVA); and spherical
equivalent (SE). Near and intermediate visual acuities were
measured using the Rosenbaum near acuity card (Richmond
Products, Inc.) held at distances of 33cm and 60cm,
respectively. Clinical data was collected preoperatively and 1,
3, 6, 12, 24, and 36 months postoperatively for each eye.
At the last followup, patients satisfaction, their inde-
pendence from using glasses, and the perception of photic
phenomena were assessed by a subjective questionnaire
developed by the author. The subjects were speciﬁcally
queried about glare (trouble seeing street signs due to bright
light or oncoming headlights) and halos (rings around
lights). Patients rated the eﬀect of each phenomenon on a
scale from 0 to 3, with 0 meaning not observed, 1 as easily
tolerated (interpreted as mild), 2 being deﬁned as moderate,
and 3 being deﬁned as severe.
All patients were operated using the same technique.
All patients were topically anesthetised by lidocaine 2% gel
before surgery. A 2.75mm self-sealing clear cornea incision
was made on the temporal side. Sodium hyaluronate 3%—
chondroitin sulfate 4% (Viscoat) was used to reform and
stabilize the surgical planes and protect the endothelium. A
5.00 to 5.25mm continuous curvilinear capsulorhexis was
initially performed with a 26-gauge needle and completed
with forceps. Phacoemulsiﬁcation was performed using the
Inﬁnity machine (Alcon Surgical) or Sovereign machine
(Allergan Surgical). All IOLs were planned to be inserted in
the capsular bag with the injector system. The viscoelastic
materialwascompletelyremovedattheendoftheprocedure.
No sutures were used in any case. In patients with corneal
astigmatism, between 0.75D and 1,50D, veriﬁed by topog-
raphy, limbal relaxing incisions were performed according
to Gill’s modiﬁed nomogram. Postoperative medication
included moxiﬂoxacin (Vigamox) or gatiﬂoxacin (Zymar) 4
times a day for 2 weeks, 0.1% diclofenaco sodium (Voltaren)
3 times a day for 4 weeks, and steroid (Predfort) eyedrops
4 times a day for 6 weeks. The minimum postoperative
followup for inclusion in the study was 3 months.
The enhancement rate was also evaluated, that is, the
quantity of cases in which a second procedure was needed to
achieve the desired refractive result. The types of procedures
used in enhancement were also described.
All data analysis was performed using SPSS statistical
software package for Windows (version 17.0 SPSS Inc.
Chicago, IL). For statistical analysis of visual acuity, loga-
rithms of minimum angle of resolution (logMAR) acuity
values were used. Descriptive statistics (mean, minimum,
maximum, SD) were calculated for age, spherical equivalent,
refraction, and visual acuity. The paired-sample t-test was
used to compare preoperative and postoperative spherical
equivalents.AP valuelessthan.05wasconsideredstatistically
signiﬁcant.
3. Results
Two thousand and ﬁve hundred eyes of 1558 patients
were included in the study. One thousand and seventy one
(68.7%) were women, and 487 (31.3%) were men. Nine
hundred and forty two patients (60.5%) received bilateral
implants while 616 patients (39.5%) received unilateral
implants.Themeanageofthepatientswas66.17years ±8.94
(SD) (range 34 to 87 years) (Table 1). Patients were followed
up for an average of 13.6 months (range 3 to 36 months). In
1042eyes(41.68%),associatedlimbalrelaxingincisionswere
made.
Preoperatively, the mean logMAR UDVA of these eyes
was 0.61 ± 0.35 (range 0 to 1.3). After a followup of 36
months postoperatively, the mean UDVA was 0.06 ± 0.09
(range 0 to 0.54). The UDVA was signiﬁcantly better at all
followup periods compared to that before referral (P<. 05).
In Table 2, shows the UDVA in diﬀerent periods during theJournal of Ophthalmology 3
Table 1: Preoperative characteristics of the patients (N = 1558).
Characteristics Value
Sex, n (%)
Male 487 (31.3)
Female 1071 (68.7)
Age (y)
Mean ± SD 66.17 ± 8.94
Range 34 – 87
Mean CDVA (logMAR) ± SD 0.13 ± 0.17
Mean SE (D) ± SD +1.02 ± 2.22
CDVA = corrected distance visual acuity; SE = spherical equivalent.
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Figure 1: UDVA in diﬀerent periods of followup.
followup. In Figure 1, it can be observed that an UDVA of
0.10 or better was achieved by 67.64% of the eyes in all
periods of followup. It was also found that, no matter what
f o l l o w u pp e r i o dw a so b s e r v e d ,aU D V Ao f0 . 1 8o rb e t t e rw a s
achievedinapproximately85%oftheeyes.Finally,itwasalso
observed in all followup periods that an UDVA of 0.30 or
better was achieved in approximately 95% of the eyes.
Preoperatively, the mean logMAR CDVA of these eyes
was 0.13 ± 0.17 (range 0 to 1.3); After the surgery, with an
average followup, the mean logMAR CDVA of patients was
0.01 ± 0.03 (range 0 to 0.3), this was signiﬁcantly better than
before referral (P<. 05); Table 3.
The average SE at referral of these eyes was +1.02D
(range −12.50 to +12.25D). Five hundred and ﬁfty ﬁve
eyes (22.2%) had myopic spherical equivalent, the mean
was −2.07 (range −12.50 to −0.25D). Ninety seven eyes
(3.88%) emmetrope SE and, ﬁnally, 1848 eyes (73.92%)
had hyperopic spherical equivalent, the mean was +2.01
(range +0.25 to +12.25D). Postoperatively, the average SE
was +0.08D (range −0.75 to +1.25D). Table 4 and Figure 2
show the SE in diﬀerent periods during the followup.
Table 5 showstheuncorrectednearvisualacuity(UNVA)
performance of these eyes in each postoperative period. The
mean logMAR UNVA in all the postoperatory periods was
0.00. In all followup periods, the UNVA was found to be
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Figure 2: Spherical equivalent in pre-op and in diﬀerent periods of
followup.
better than 0.00 in 93.7% and 0.1 or better in 98% of the
eyes in study (Figure 3).
Table 6 shows the uncorrected intermediate visual acuity
(UIVA) performance of these eyes in each post operative
period. The mean logMAR UIVA in all the postoperatory
periods was 0.18. In all followup periods it was found 0.18
or better in 41% of the eyes; 0.20 or better in more than 65%
of the eyes 0.30 or better in more than 82.8% of the eyes in
study (Figure 4).
A qualitative performance analysis of the IOL, by means
of a subjective questionnaire, took into consideration only
results of patients with bilateral implants. At the last
followup, 97.87% (922 of 942 patients) of the patients were
spectacle independent for near and distant vision and 88%
(829 of 942 patients) of the patients were totally satisﬁed
with their quality of vision. After an average followup of
13.6 months, for glare after the second implant, of the 942
patients who answered the question 6.1% (n = 58) rated
their observation as severe in eﬀect, 26.2% (n = 247) rated
it as moderate, and 67.7% (n = 637) rated it as none or
mild. Halos were reported as severe by 2.12% of patients
(n = 20), moderate by 16.45% (n = 155), and absent or mild
by 81.43% (n = 767). No other complaints were reported.
With regard to enhancement, 5.24% (131 out of 2500
eyes) needed to undergo a second procedure in order to
achieve the desired refraction result. 57 eyes (2.28%) were
submitted to excimer laser correction, while 74 eyes (2.96%)
had the optical zone of the IOL placed over the capsulorhexis
(buttoning of the optical zone in the capsulorhexis for
slight residual hyperopia correction). The following was also
undertaken: Pars Plana vitrectomy in 26 eyes (1.04%); YAG
laser in 88 eyes (3.52%). There were retina detachment in
1 eye, cystoid macular edema in 5 eyes, and rupture of the
posterior capsule in 14 eyes. In 3 of the 14 eyes with rupture
of the posterior capsule, the IOL was ﬁxed on the iris. No
implant replacement was done.4 Journal of Ophthalmology
Table 2: UDVA in diﬀerent periods during the followup.
PRE- Postoperatory
Pre-op 3◦ mth 6◦ mth 12
◦ mth 24
◦ mth 36
◦ mth
0.00 57 (2.28%) 1059 (42.36%) 1193 (47.77%) 1199 (48.34%) 433 (56.52%) 74 (57.81%)
0.10 117 (4.68%) 632 (25.28%) 606 (24.26%) 675 (27.21%) 185 (24.15%) 28 (21.87%)
0.18 162 (6.48%) 441 (17.64%) 456 (18.26%) 435 (17.54%) 111 (14.49%) 23 (17.96%)
0.30 344 (13.76%) 234 (9.36%) 171 (6.84%) 128 (5.16%) 28 (3.65%) 3 (2.34%)
0.40 194 (7.76%) 77 (3.08%) 34 (1.36%) 31 (1.25%) 3 (0.39%) —
0.48 231 (9.24%) 37 (1.48%) 20 (0.8%) 6 (0.24%) 3 (0.39%) —
0.54 259 (10.36%) 14 (0.56%) 14 (0.56%) 6 (0.24%) 3 (0.39%) —
0.60 145 (5.8%) 3 (0.12%) 3 (0.12%) — — —
0.70 202 (8.08%) 3 (0.12%) — — — —
0.88 316 (12.64%) — — — — —
1.00 202 (8.08%) — — — — —
1.18 20 (0.8%) — — — — —
1.30 251 (10.04%) — — — — —
Total 2500 2500 2497 2480 766 128
100% 100% 100% 100% 100% 100%
Table 3: CDVA in diﬀerent periods during followup.
PRE- Postoperatory
Pre-op 3◦ mth 6◦ mth 12
◦ mth 24
◦ mth 36
◦ mth
0.00 1082 (43.28%) 2048 (81.9%) 2079 (83.25%) 2075 (83.67%) 702 (91.65%) 116 (90.63%)
0.10 524 (20.96%) 361 (14.46%) 365 (14.61%) 359 (14.48%) 54 (7.05%) 9 (7.04%)
0.18 342 (13,68%) 74 (2.96%) 46 (1.84%) 42 (1.69%) 6 (0.78%) 2 (1.55%)
0.30 328 (13.12%) 12 (0.46%) 5 (0.21%) 3 (0.11%) 4 (0.52%) 1 (0.78%)
0.40 99 (3.96%) 5 (0.22%) 2 (0.09%) 1 (0.05%) — —
0.48 41 (1.64%) — — — — —
0.54 18 (0.72%) — — — — —
0.60 18 (0.72%) — — — — —
0.70 20 (0.80%) — — — — —
0.88 8 (0.32%) — — — — —
1.00 18 (0.72%) — — — — —
1 . 1 8 ——— —— —
1.30 2 (0.08%) — — — — —
Total 2500 2500 2497 2480 766 128
100% 100% 100% 100% 100% 100%
Table 4: Spherical equivalent in diﬀerent periods during followup.
PREOP 3 months 6 months 12 months 24 months 36 months
SE Myopia
N 555 541 652 603 159 28
% of patients 22.2 21.64 26.11 24.31 20.75 21.87
Mean (D) −2.7 −0.42 −0.46 −0.44 −0.40 −0.37
SE Emmetropia
N 97 760 755 786 299 54
% of patients 3.88 30.40 30.23 31.69 39.03 42.18
SE Hyperopia
N 1848 1199 1090 1090 308 46
% of patients 73.92 47.96 43.65 43.95 40.20 35.93
Mean (D) +2.01 +0.51 +0.46 +0.43 +0.42 +0.43
SE: spherical equivalent.Journal of Ophthalmology 5
Table 5: UNVA in each postoperative period.
3◦ mth 6◦ mth 12
◦ mth 24
◦ mth 36
◦ mth
0.00 2343 (93.72%) 2440 (97.71%) 2434 (98.14%) 763 (99.6%) 128 (100%)
0.10 114 (4.56%) 40 (1.6%) 29 (1.16%) 3 (0.4%) —
0.18 29 (1.16%) 9 (0.36%) 14 (0.56%) — —
0.20 14 (0.56%) — 3 (0.12%) — —
< 0.20 — 8 (0.32%) — — —
Total 2500 2497 2480 766 128
100% 100% 100% 100% 100%
Table 6: UIVA in each postoperative period.
3◦ mth 6◦ mth 12
◦ mth 24
◦ mth 36
◦ mth
0.00 171 (6.84%) 148 (5.92%) 142 (5.72%) 40 (5.22%) 17 (13.28%)
0.10 393 (15.72%) 384 (15.37%) 407 (16.41%) 134 (17.49%) 26 (20.31%)
0.18 492 (19.68%) 495 (19.82%) 544 (21.93%) 159 (20.75%) 37 (28.9%)
0.20 584 (23.36%) 638 (25.55%) 652 (26.29%) 199 (25.97%) 23 (17.96%)
0.30 430 (17.2%) 518 (20.74%) 470 (18.95%) 140 (18.27%) 8 (6.25%)
0.40 330 (13.2%) 271 (10.85%) 231 (9.31%) 85 (11.09%) 17 (13.28%)
0.48 74 (2.96%) 34 (1.36%) 34 (1.37%) 9 (1.17%) —
0.50 26 (1.04%) 9 (0.36%) — — —
Mean UCIVA J 3.85 J 3.79 J 3.69 J 3.72 J 2.47
Total 2500 2497 2480 766 128
100% 100% 100% 100% 100%
4. Discussion
The loss of accommodation following cataract surgery and
the restoration of near vision in patients with IOL implan-
tation remains a challenging problem of modern cataract
surgery. Because the natural process of accommodation is
notrestored,amonofocalIOLneedscomplementaryreading
or multifocal glasses to create good vision at more than one
distance. Recently, multifocal IOLs have been investigated
and gained wide popularity.
T h eﬁ r s tm u l t i f o c a lI O La p p r o v e df o rg e n e r a lu s ei nt h e
United States is the Array (AMO, Advanced Medical Optics,
Santa Ana, California) [10]. The Array is a zonal progressive
intraocular lens with ﬁve concentric zones on the anterior
surface. Zones 1, 3, and 5 are distance dominant zones
whereas zones 2 and 4 are near dominant. The lens has an
aspheric design, and each zone repeats the entire refractive
sequence, corresponding to distant, intermediate, and near
foci. A study that evaluated the clinical outcomes and patient
satisfaction after implantation of multifocal IOLs found that
multifocal IOLs are more eﬀective at improving uncorrected
near vision acuity (UNVA) and have a reduced spectacle
dependence for near and distant vision relative to monofocal
IOLs [11].
The development of the prolate aspherical monofocal
Tecnis IOL was a major step toward the reduction of ocular
spherical aberration, resulting in improved visual function,
particularly contrast vision. It was therefore a logical step to
incorporate the aspherical IOL platform into the design of
a new multifocal IOL to counteract the negative impact of
multifocal IOL design on contrast vision [12]. Based on the
favorable optical performance of a diﬀractive PMMA bifocal
IOL (811E, Pharmacia) [13] ,ad i ﬀractive optic design was
then applied to the multifocal Tecnis IOL, with the result
being the Tecnis ZM900. The Tecnis (AMO - Model ZM900)
multifocal IOL is a second-generation silicone diﬀractive 3-
piecelens.TheinnovativeaspectoftheTecnismultifocalIOL
is an anterior modiﬁed prolate surface, which neutralizes the
negative impact of spherical aberrations on function vision,
and a posterior full diﬀractive multifocal surface with the
addition power of +4.0 at lens plane. The present study
presents a large number of surgeries with a long longitudinal
followup.
The diﬀractive IOLs use diﬀraction and interference to
form multiple discrete foci. These IOLs can be considered
conventional monofocal lenses with the diﬀractive element
on one surface. The eﬀect of the diﬀractive element is to split
most of the incident light into the zeroth (distance) and ﬁrst
(near) diﬀracted orders. Of the incident light, approximately
41% goes to the near foci, 41% to the distance foci, and the
remaining light goes into higher orders. The full-aperture
diﬀractivemaintainstheratioforallpupilsizes.Atheoretical
study on model eyes showed that diﬀr a c t i v em u l t i f o c a lI O L s
are superior to refractive multifocal IOLs for near vision
whereas for distant vision they are comparable [14].
Although the Tecnis multifocal IOL made of acrylic
is presently available, this study brings together results of
implants with the IOL made of silicone. The reason being6 Journal of Ophthalmology
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Figure 3: Post-op UNVA in diﬀerent periods of followup.
that, whereas the silicone IOL has been used since January
2006, the acrylic IOL only came on the market in June 2008.
We believe that the availability of this new material will make
a further contribution to the improved quality of vision,
reducing modulation transfer function (MTF) through the
correction of chromatic aberration. We have already begun a
new study to evaluate the performance of the acrylic IOL.
In order to analyze IOL quantitative performance, results
of patients who received unilateral implants as well as
patients who got Tecnis multifocal lenses in both eyes were
studied. That is because evaluations of visual acuity and
refraction in each eye were individualized. In other words,
the analysis was made of the contralateral occluded eye. As
for the IOL qualitative analysis made through a subjective
questionnaire, only the results of patients who underwent
bilateral implants were used. The reason for this is that the
observations were made by the patient during day-to-day
activities, that is, with both eyes open; a diﬀerent condition
from contralateral eye (e.g., phakic eye, with monofocal
IOL implant or with a multifocal IOL implant that is
not Tecnis) would alter patient observations compromising
results (positive or negative) related exclusively of the Tecnis
IOL.
Numerous studies have already shown the excellent
quantitativeandqualitativeperformanceofTecnismultifocal
IOLs [5, 6, 9]. Cillino et al. [15]. found that the new-
generation multifocal IOLs (Tecnis ZM900) provided better
near vision, equivalent intermediate vision, less unwanted
photic phenomena, and greater spectacle independence than
eithermonofocal(AR40,AMO)orrefractivemultifocalIOLs
(ReZoom, AMO; Array, AMO). Contrary to ﬁndings of
Cillino et al., a study by Palmer et al. [16] showed a better
visualfunctionandlesserphoticphenomenawithmonofocal
IOLs (Tecnis Z900, AMO) compared to multifocal IOLs
(Tecnis ZM900, AMO; ReZoom, AMO; TwinSet, Acri.Tec)
but patients were spectacle dependent. Artigas et al. [17],
also analyzed the image quality (MTF) of 4 IOLs (ReSTOR,
Alcon; Tecnis ZM900, AMO; ReZoom, AMO; SN60WF,
Alcon) and observed that the reference monofocal IOL
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Figure 4: Post-op UIVA in diﬀerent periods of followup.
provided better distance images than any multifocal IOL
with all pupil sizes. In a retrospective study by Ngo et
al. [18], 108 eyes of 54 patients received 1 of 3 IOLs
(Tecnis ZM900, SA60D3, SN60D3). All three IOLs provide
similar uncorrected and best corrected distance visual acuity.
However, the ZM900 IOL provided better binocular distance
corrected and uncorrected near acuity than the 2 other
lenses.
In the present study, the mean UDVA reached excellent
levels in all the followups. Other studies describing Tecnis
ZM900 multifocal IOL also achieved similar results. In a
prospective study by Cillino et al. [15], eyes that received the
Tecnis ZM900 IOL achieved a mean logMAR UDVA of 0.18
after 1 year of followup. Ngo et al. [18] also found a mean
logMAR UDVA of 0.10 after 3 months of followup, with an
UDVA of 20/20 or better in 30.0% of the eyes implanted with
Tecnis ZM900, an UDVA of 20/30 or better in 86.6%, and
an UDVA of 20/40 or better in 96.7% of the eyes. Santhiago
and associates [19] conducted a prospective study in which
40 eyes of 20 patients received one of two multifocal IOLs
(Tecnis ZM900, and ReSTOR SN60D3). After 3 months of
followup the mean logMAR UDVA was 0.12 and 0.14 in the
Tecnis ZM900 and ReSTOR group, respectively.
In all followups, the mean UIVA and UNVA reached
clinically useful values, better than 20/30 (0.18) in 41% and
better than 20/25 (0.10) in 98% of the eyes, respectively.
In a study by Cillino and associates, they also found that
Tecnis ZM900 IOL provided a signiﬁcant improvement
in UIVA and UNVA, with a mean of 20/23 and 20/25,
respectively. Palmer et al. conducted a prospective study in
which 114 patients (228 eyes) received one of four IOLs
(Tecnis Z9000, Tecnis ZM900, ReZoom, Acri.Tec) [16]. At
the last followup, patients implanted with the Tecnis ZM900
showed signiﬁcant better UNVA compared with others IOLs.
In another study of H¨ utz et al. [9], they retrospectively
evaluated reading performance at intermediate distances
of three types of multifocal IOLs (Tecnis ZM001, Array,
ReSTOR) under diﬀerent light conditions based on reading
acuity and reading speed tests and the Tecnis IOL providedJournal of Ophthalmology 7
better uncorrected reading speed at intermediate distances
than array and ReSTOR IOLs.
In our study, the use of limbal relaxing incisions (LRIs)
during implantation of the Tecnis ZM900 multifocal IOL
was done in 41.68% of the surgeries. Estimates of the
incidence of naturally occurring astigmatism vary; it has
been reported that at time of cataract surgery in a general
population, the cylinder is more than 2.00 diopters (D)i n
approximately 10% of patients, between 1.00D and 2.00D
in 20% and less than 1.00D in 70% [20]. Although it is
possible to reduce astigmatism with LRIs, further correction
with LASIK may be needed for larger amounts of residual
sphericalandcylindricalerrors[21].Also,becausemultifocal
IOLs split the light, patients with these IOLs may be more
sensitive to changes caused by residual astigmatism. Other
studies of multifocal IOL implantation combined with LRIs
were also eﬀective and safe in reducing pre-existing corneal
astigmatism [21, 22].
Despite advances in IOL calculation, there may be a
residual refractive error after multifocal IOL implantation
that necessitates correction with spectacles or another
surgery to provide satisfactory distance and near acuity [23].
The best strategy for a second procedure (enhancement)
should be decided upon by taking into account not only the
situation to be corrected, but eye conditions as well. A new
refractive surgery, a secondary additional implant and even a
change of IOL, are some examples. Five percent of the eyes
(n = 131) needed to undergo a second procedure in order to
achieve the desired refraction result. Fifty seven eyes (2.28%)
were submitted to excimer laser correction. Studies [24, 25]
also report good results for the correction of refractive
errors with LASIK or photorefractive keratectomy (PRK)
after multifocal IOL implantation. Alfonso et al. [26]f o u n d
good outcomes in 53 eyes of 31 patients that had LASIK for
residual refractive error after refractive lens exchange (RLE)
with implantation of an AcrySof ReSTOR IOL. Recently,
Muftuogluetal.[27]alsoreportedthatLASIKafterRLEwith
AcrySofReSTORIOLimplantationwaseﬀectivein85eyesof
59 patients.
In this study, 74 eyes (2.96%) had the IOL optic captured
through the continuous curvilinear capsulorhexis (CCC)
anteriorly to correct a residual refractive error. A change
occurs in the position of the IOL optical zone: moving it to a
forward position, so the optical zone buckles on the anterior
capsulorrexis (for the correction of small hyperopic errors),
or moving it backward, so the optical zone buckles on a
posteriorcapsulorrexisthatiscreated(forcorrectionofsmall
myopic errors). These are viable alternatives in cases where a
new corneal procedure is impossible. We ﬁrst describe this
technique of anterior optic capture of a multifocal IOL to
correct residual refractive error in 2009 [27].
The results show the improvement that can be achieved
after implantation of these lenses, which have characteristics
that can correct distant, intermediate, and near vision after
cataract surgery. We believe that IOL selection should be
based on patient preference and daily activities. Overall, the
useofaTecnisZM900multifocalIOLappearstobeasafeand
eﬃcient procedure and a good refractive solution. Attention
to detail in regard to proper patient selection, preoperative
measurements, intraoperative technique, and postopera-
tive management has resulted in excellent outcomes and
improved patient acceptance of this eﬀective technique. As
with all refractive procedures, realistic expectations should
be established prior to surgical intervention.
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